How clinical trials are adopting cybersecurity best practice

Healthcare data breaches reached a record high in 2023 due to the transition to virtual care and clinical trials during the COVID-19 pandemic, exposing sensitive patient data. To counter this, pharmaceutical companies and healthcare providers are predicted to spend $9.77 billion on cybersecurity by 2025. Cybersecurity company RWS is taking steps to strengthen patient data security, offering redaction services for sensitive health information and regularly updating cybersecurity protocols.